Die veränderten Rahmenbedingungen aus Sicht der Hersteller Auswirkungen und Handlungsoptionen
07/26/2010
Rate this Video:
(Be the First!)
Henning Anders | arzneimitteldistribution | pharmaceutical distribution | European distribution | European Model Hub | warehouse management | good distribution practice | value added services | direct-to-patient | direct-to-pharmacy | DTP | distribution models
Henning Anders | arzneimitteldistribution | pharmaceutical distribution | European distribution | European Model Hub | warehouse management | good distribution practice | value added services | direct-to-patient | direct-to-pharmacy | DTP | distribution models
Der vollversorgende herstellerneutrale Pharmagroßhandel in Deutschland
Europa und die 15. AMG-Novelle
Distributionskonzepte nach Inkrafttreten der 15. AMG - Novelle
Fazit
-
Improving Processes and Delivering Business Benefits Through QbD: Milling of an API -
Building Quality from the Beginning -
Laurel LaBauve Speaks about Merck Sigma -
Using Lean Six Sigma to Benefit Pharmaceutical Sales and Marketing and R&D -
Formulations for Toxicology Studies -
Aktuelle Trends in der Arzneimitteldistribution: Welche innovativen Distributionswege sind denkbar? -
Getting the Best Out of Your CRO: Best Practice Techniques for Small Companies -
Risk Management in IT Outsourcing: The Shared Stake Perspective in Multinational Corporations -
Best Practice Strategies for Managing CROs -
Interview mit Eberhard Lüdtke, Lundbeck GmbH
You Should Check Out:
* = required.
Not a member yet? Sign up
Events of Interest
-
Pharma Sales Force 2010
Mélia Hotel, Berlin
October 18- 21, 2010 -
Nordic Pharmaceutical Distribution
Copenhagen, Denmark
February 15- 17, 2011 -
2nd Successful eCTD Lifecycle Management
Marriot Prague, Prague, Czech Republic
September 14- 15, 2010 -
6th International Conference Compound libraries 2010
Barceló Cologne City Center, Cologne, Germany
September 14- 16, 2010
You Might Also Like
-
Aktuelle Trends in der Arzneimitteldistribution: Welche innovativen Distributionswege sind denkbar?
Arzneimitteldistribution in Deutschland eine Bestandsaufnahme Einfluss der 15. AMG-Novelle auf die
-
Was sind die Herausforderungen auf der letzten Meile zum Patienten?
In diesem Interview spricht Walter Heider, Director Commercial Department und Business Development bei der
Pharma IQ
-
How the Role of the Wholesaler has Evolved in a Complex Supply Chain
Pharma IQ caught up with Monika Derecque-Pois, Director General of the European Association of...Read more
Monika Derecque-Pois
-
Will a Centralised DC Help Lower Inventory Levels?
The conventional wisdom on inventory management is that centralising inventory in a single place will lower...Read more
Jim Panos
